Cardiovascular Development and Regeneration
Organizer(s): Katherine E. Yutzey and Deepak SrivastavaDate: January 22 - 27, 2012
Location: Sagebrush Inn & Suites, Taos, NM, USA
Cardiovascular disease is the leading cause of death worldwide, affecting both children and adults. There is increasing evidence that developmental mechanisms of cardiac cell lineage differentiation and organogenesis contribute to cardiovascular disease throughout life and could be leveraged for regenerative therapies. This meeting will emphasize shared molecular mechanisms in cardiovascular development and disease. Sessions on cardiovascular lineage specification and stem cell biology will emphasize common molecular mechanisms with therapeutic potential in heart regeneration. Discussion of bioengineering and tissue-based therapies will complement these sessions, with the aim of facilitating translational approaches. Recent advances in cardiac organogenesis and the genetics of human congenital heart disease will be presented in order to promote mechanistic connections in heart development and disease. Overall, the goal of the meeting is to bring together researchers with expertise in cardiac embryology, molecular biology, stem cell biology, human genetics and tissue engineering to facilitate new scientific directions and therapeutic approaches in the management and treatment of cardiovascular disease in children and adults.
Scholarship Deadline: September 21 2011
Discounted Abstract Deadline: September 21 2011
Abstract Deadline: October 24 2011
Discounted Registration Deadline: November 22 2011
We gratefully acknowledge additional support for this conference from:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL110472-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.